GBS Venture Partners

GBS Venture Partners

GBS Vebture Partners is a life science venture capital and management firm.

All edits

Edits on 3 Aug, 2020
Lax Mariappan
Lax Mariappan edited on 3 Aug, 2020
Edits made to:
Infobox (+2 properties)
Infobox
Founder
Geoff Brooke
Edits on 6 Mar, 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 6 Mar, 2020
Edits made to:
Article (+20/-20 characters)
Article

GBS Venture Partners or GBS is a venture capital firmventure capital firm focused on private or public companies in areas of human healthcare, biotechnology product development, and life science.

Edits on 31 Jan, 2020
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 31 Jan, 2020
Edits made to:
Article (+7/-7 characters)
Article

Its investments include Moximed, Elastagen, IvantisIvantis, AirXpanders, Spinifex Pharmaceuticals, and Neurovance.

Edits on 23 Jan, 2020
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 23 Jan, 2020
Edits made to:
Article (+9/-9 characters)
Article

Brigitte Smith and Geoff Brooke founded GBS Venture Partners in 1996. It invests in companies developing and commercializing biological or small molecule therapeutics, medical devices, and diagnostics products in AustraliaAustralia. Its previous funds include The Australian, Bioscience Trust , GBS Bioventures II , The Genesis Fund , and GBS Bioventures III .

Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 22 Jan, 2020
Edits made to:
Article (+11/-11 characters)
Article

Its investments include Moximed, Elastagen, Ivantis, AirXpandersAirXpanders, Spinifex Pharmaceuticals, and Neurovance.

Edits on 16 Jan, 2020
Mevludin Mešanović
Mevludin Mešanović approved a suggestion from Golden's AI on 16 Jan, 2020
Edits made to:
Article (+7/-7 characters)
Article

Its investments include MoximedMoximed, Elastagen, Ivantis, AirXpanders, Spinifex Pharmaceuticals, and Neurovance.

Edits on 24 Nov, 2019
Melanie Manipula
Melanie Manipula edited on 24 Nov, 2019
Edits made to:
Article (-1 characters)
Article

...

Melanie Manipula
Melanie Manipula edited on 24 Nov, 2019
Edits made to:
Article (-1 characters)
Article

...

Melanie Manipula
Melanie Manipula edited on 24 Nov, 2019
Edits made to:
Infobox (+8/--1 properties)
Description (+76 characters)
Article (+840 characters)
People (+2 rows) (+4 cells) (+47 characters)
Topic thumbnail

GBS Ventures GBS Venture Partners

GBS Vebture Partners is a life science venture capital and management firm.

Article

GBS Venture Partners or GBS is a venture capital firm focused on private or public companies in areas of human healthcare, biotechnology product development, and life science.

Brigitte Smith and Geoff Brooke founded GBS Venture Partners in 1996. It invests in companies developing and commercializing biological or small molecule therapeutics, medical devices, and diagnostics products in Australia. Its previous funds include The Australian, Bioscience Trust , GBS Bioventures II , The Genesis Fund , and GBS Bioventures III .

The GBS team provides strategic advice and support to portfolio companies, access specialist scientific and technical advice and introductions to international contacts and corporate collaborators .

...

Its investments include Moximed, Elastagen, Ivantis, AirXpanders, Spinifex Pharmaceuticals, and Neurovance.

People

Name
Role
LinkedIn

Brigitte Smith

Co-Founder

Geoff Brooke

Co-Founder

Infobox
Industry
Venture capital
Location
Melbourne
Company status
Active
Founded date
1996
Edits on 22 May, 2019
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 22 May, 2019
Edits made to:
Infobox (+3 properties)
Topic thumbnail

GBS Venture Partners

GBS Vebture Partners is a life science venture capital and management firm.

Infobox
Is a
Company
Aime Anne Nisay"Initial topic creation"
Aime Anne Nisay created this topic on 22 May, 2019
Edits made to:
Topic thumbnail

 GBS Ventures

GBS Vebture Partners is a life science venture capital and management firm.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.